Skip to main content
. 2003 Dec;52(12):1728–1733. doi: 10.1136/gut.52.12.1728

Table 2.

Incidence of the most frequently occurring side effects in the placebo and pegylated interferon α (PegIFN) groups

Adverse event Placebo PegIFN 0.5 µg/kg PegIFN 1 µg/kg
Haematological
    Anamia 3 2 7
    Leukopenia 2 3 4
    Thrombocytopenia 0 0 0
Hepatic
    Elevation of bilirubin 0 0 0
Gastrointestinal
    Nausea 1 2 3
    Pancreatitis 1 0 0
Fever 2 8 7
Erythema at injection site 0 10 5
Flu-like symptoms 2 11 11
Hair loss 1 1 4
Infections
    Minor infection 1 3 0
    Major infection 0 0 0
Headache 0 7 4